HRTX Q4 2021 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$162M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21M+0.2% YoY

Gross Profit

$10M47.0% margin

Operating Income

-$54M-259.2% margin

Net Income

-$55M-264.6% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

-11.1%

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$46M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$306M

Total Liabilities

$228M

Stockholders' Equity

$78M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$21M	+0.2%
Gross Profit	$10M	$11M	-13.4%
Operating Income	-$54M	-$61M	+12.7%
Net Income	-$55M	-$62M	+12.3%

Revenue Segments

C I N V A N T I

$17M84%

S U S T O L

$3M12%

Z Y N R E L E F

$824,0004%